Scott Andrew Smith, Director at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 12,000 shares at $4.09 ($49K) on 2019-06-28, disclosed to the SEC on 2019-06-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| BCAB | SELL | 2021-12-07 | $155K | — | Filing → |
| BCAB | SELL | 2021-12-06 | $10K | — | Filing → |
| BCAB | SELL | 2021-11-30 | $40K | — | Filing → |